Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FXTX4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,227
Award facts
- Contract value 100% obligated
- $5,226.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency for $5,226.76 on January 13, 2026, with an ultimate completion date of January 14, 2026. The contract covers the supply of Jardiance 25 mg tablets in quantities of 90 units, a diabetes medication commonly used in military and federal healthcare systems. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The award is a child contract executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical valued at up to $999,999,999.00 through December 2031.
This delivery order represents a routine pharmaceutical procurement supporting the Defense Logistics Agency's medical supply operations for military treatment facilities and federal healthcare programs. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its capability to efficiently fulfill government requirements for brand-name and generic medications across multiple therapeutic domains. The firm fixed-price structure and rapid completion timeline reflect the nature of standard pharmaceutical replenishment orders within the Defense Logistics Agency's Medical Supply Chain, ensuring timely delivery of critical diabetes medications to federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FXTX4?
SPE2DR26FXTX4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FXTX4 worth?
The government has obligated $5,227 on SPE2DR26FXTX4.
Is contract SPE2DR26FXTX4 an order under another contract?
Yes. SPE2DR26FXTX4 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXTX4 competed?
The extent of competition for SPE2DR26FXTX4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award